NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee | Biotech Hunter

Enrollment

761

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

June 30, 2017

Conditions

Osteoarthritis, HipOsteoarthritis, KneeArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Interventions

DRUG

CR845 tablet 1 mg

CR845 tablets will be provided as 1 mg enteric-coated tablets. All tablets are white in color with no markings and are identical in appearance, regardless of dose and treatment.

DRUG

CR845 tablet 2.5 mg

CR845 tablets will be provided as 2.5 mg enteric-coated tablets. All tablets are white in color with no markings and are identical in appearance, regardless of dose and treatment.

DRUG

CR845 tablet 5 mg

CR845 tablets will be provided as 5 mg enteric-coated tablets. All tablets are white in color with no markings and are identical in appearance, regardless of dose and treatment.

DRUG

Placebo tablet

Placebo tablets will be provided as enteric-coated tablets. All tablets are white in color with no markings and are identical in appearance, regardless of dose and treatment.

Trial Locations (35)

13901

Cara Therapeutics Study Site, Binghamton

14609

Cara Therapeutics Study Site, Rochester

16635

Cara Therapeutics Study Site, Duncansville

22911

Cara Therapeutics Study Site, Charlottesville

29406

Cara Therapeutics Study Site, Charleston

29407

Cara Therapeutics Study Site, Charleston

29601

Cara Therapeutics Study Site, Greenville

31406

Cara Therapeutics Study Site, Savannah

32806

Cara Therapeutics Study Site, Orlando

33030

Cara Therapeutics Study Site, Homestead

33143

Cara Therapeutics Study Site, South Miami

33183

Cara Therapeutics Study Site, Miami

33317

Cara Therapeutics Study Site, Plantation

33458

Cara Therapeutics Study Site, Jupiter

33462

Cara Therapeutics Study Site, Lake Worth

33634

Cara Therapeutics Study Site, Tampa

34677

Cara Therapeutics Study Site, Oldsmar

35216

Cara Therapeutics Study Site, Birmingham

45242

Cara Therapeutics Study Site, Cincinnati

45246

Cara Therapeutics Study Site, Cincinnati

63042

Cara Therapeutics Study Site, Hazelwood

68134

Cara Therapeutics Study Site, Omaha

73119

Cara Therapeutics Study Site, Oklahoma City

75024

Cara Therapeutics Study Site, Plano

75075

Cara Therapeutics Study Site, Plano

75234

Cara Therapeutics Study Site, Dallas

78209

Cara Therapeutics Study Site, San Antonio

78731

Cara Therapeutics Study Site, Austin

85023

Cara Therapeutics Study Site, Phoenix

85351

Cara Therapeutics Study Site, Peoria

89144

Cara Therapeutics Study Site, Las Vegas

92123

Cara Therapeutics Study Site, San Diego

92780

Cara Therapeutics Study Site, Tustin

95608

Cara Therapeutics Study Site, Carmichael

08009

Cara Therapeutics Study Site, Berlin